These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3156645)

  • 21. [Medroxyprogesterone-acetate in gynecologic endocrinology].
    Presl J
    Cesk Gynekol; 1987 Feb; 52(1):60-4. PubMed ID: 2952299
    [No Abstract]   [Full Text] [Related]  

  • 22. Post-menopausal medroxyprogesterone acetate treatment: short-term effects on the hemostatic system.
    Bertaglia E; Mozzanega B; Azzurro M; Belmonte P; Marchesoni D
    Haematologica; 1985; 70(4):370. PubMed ID: 2934302
    [No Abstract]   [Full Text] [Related]  

  • 23. Myeloprotective effect of diethyldithiocarbamate treatment following 1,3-bis(2-chloroethyl)-1-nitrosourea, adriamycin, or mitomycin C in mice.
    Schmalbach TK; Borch RF
    Cancer Res; 1989 May; 49(10):2574-7. PubMed ID: 2540902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.
    Grzegorzewski K; Ruscetti FW; Usui N; Damia G; Longo DL; Carlino JA; Keller JR; Wiltrout RH
    J Exp Med; 1994 Sep; 180(3):1047-57. PubMed ID: 8064224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adriamycin action on human breast cancer cells: enhancement by medroxyprogesterone acetate.
    Shaikh NA; Owen AM; Ghilchik MW; Braunsberg H
    Int J Cancer; 1989 Apr; 43(4):733-6. PubMed ID: 2522913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anabolizing and anti-pain effect of the short-term treatment with medroxyprogesterone acetate (MAP) at high oral doses in oncology.
    Pannuti F; Burroni P; Fruet F; Piana E; Strocchi E; Di Marco AR; Cricca A; Camaggi CM
    Panminerva Med; 1980; 22(3):149-56. PubMed ID: 6451859
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate.
    Fioretti P; Gambacciani M; Spinetti A; Cagnacci A; Paoletti AM; Felipetto R; Melis GB
    Ann N Y Acad Sci; 1991; 622():302-6. PubMed ID: 1829595
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic trial of medroxyprogesterone acetate in severe fibrocystic breast disease].
    Peralta O; Campodónico I
    Rev Chil Obstet Ginecol; 1983; 48(3):146-55. PubMed ID: 6241963
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of hyperthermia at 40.5 degrees C and cytostatic drugs on human bone marrow progenitor cells.
    Neumann HA; Engelhardt R
    Recent Results Cancer Res; 1988; 109():57-63. PubMed ID: 3175299
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of medroxyprogesterone acetate on cerebral blood flow].
    Ikeda T; Kaneko M; Mori N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):285-6. PubMed ID: 2139690
    [No Abstract]   [Full Text] [Related]  

  • 31. [Myelopoietic effect of medroxyprogesterone acetate at high parenteral doses in the cancer patient].
    Gustavo Gercovich F; Morgenfeld E; Dragosky M; Murro H; Sorrentino M; Presman A; Martínez RE
    Sangre (Barc); 1982; 27(5):883-90. PubMed ID: 7167850
    [No Abstract]   [Full Text] [Related]  

  • 32. Differences in uptake of adriamycin and daunomycin by normal BM cells and acute leukemia cell determined by flow cytometry.
    Sonneveld P; van den Engh GJ
    Leuk Res; 1981; 5(3):251-7. PubMed ID: 7266019
    [No Abstract]   [Full Text] [Related]  

  • 33. Actions of medroxyprogesterone acetate on the efficacy of cytotoxic drugs: studies with human breast cancer cells in culture.
    Shaikh N; Owen AM; Ghilchik MW; Braunsberg H
    Int J Cancer; 1989 Mar; 43(3):458-63. PubMed ID: 2522422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of inflammatory breast cancer treated with medroxyprogesterone acetate (MPA) in combination with intra-arterial infusion chemotherapy].
    Yamada T; Okazaki M; Okazaki A; Sato H; Watanabe Y; Toda K; Okazaki Y; Asaishi K; Hirata K; Narimatsu E
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1923-5. PubMed ID: 1387777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats.
    Formelli F; Zaccheo T; Casazza AM; Bellini O; Di Marco A
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1211-21. PubMed ID: 6460631
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of the mutagenicity of medroxyprogesterone acetate in vitro and in vivo.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1995 Mar; 45(3):311-4. PubMed ID: 7741792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of medroxyprogesterone acetate on submandibular salivary gland of female mice.
    Nogueira-Campos CR; Melhado RM
    J Nihon Univ Sch Dent; 1984 Dec; 26(4):310-5. PubMed ID: 6241631
    [No Abstract]   [Full Text] [Related]  

  • 38. Pesticide induced alterations in marrow physiology and depletion of stem and stromal progenitor population: an experimental model to study the toxic effects of pesticide.
    Chatterjee S; Basak P; Chaklader M; Das P; Pereira JA; Chaudhuri S; Law S
    Environ Toxicol; 2014 Jan; 29(1):84-97. PubMed ID: 21987380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medroxyprogesterone acetate antiandrogen treatment of hypersexuality in a pedophiliac sex offender.
    Cordoba OA; Chapel JL
    Am J Psychiatry; 1983 Aug; 140(8):1036-9. PubMed ID: 6223535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of high dose medroxyprogesterone acetate on endogenous granulocyte macrophage-colony stimulating factor secretion and bone marrow cellularity in patients under cytotoxic chemotherapy.
    Aydin F; Demirkazik A; Içli F; Akbulut H; Samur M
    J Chemother; 1998 Oct; 10(5):394-8. PubMed ID: 9822358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.